One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: Bevacizumab and Irinotecan in Recurrent Glioblastoma.
Mellinghoff, Ingo K. MD 1,2,,
doi : 10.1200/JCO.23.01865
Volume 41(32) pgs. 4943-5075 November 10, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
Friedman, Henry S.; Prados, Michael D.; Wen, Patrick Y.; Mikkelsen, Tom; Schiff, David; Abrey, Lauren E.; Yung, W.K. Alfred; Paleologos, Nina; Nicholas, Martin K.; Jensen, Randy; Vredenburgh, James; Huang, Jane; Zheng, Maoxia; Cloughesy, Timothy
doi : 10.1200/JCO.22.02772
Meeting Exercise Recommendations Is Beneficial for Cancer Survivors.
Kenfield, Stacey A. SM, ScD 1,2,,; Chan, June M. ScD 1,2,
doi : 10.1200/JCO.23.01528
Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs.
Booth, Christopher M. MD 1,2,3; Eisenhauer, Elizabeth A. MD 2; Gyawali, Bishal MD, PhD 1,2,3,; Tannock, Ian F. MD, PhD 4,
doi : 10.1200/JCO.23.01423
Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective.
Pavic, Matea MD 1,; Wolfer, Anita MD, PhD 1; Li, Qiyu PhD 1; Gircys, Arunas MD 1; Juritz, Stephanie MD 1; Wicki, Andreas MD, PhD 2,3,; Cerny, Thomas MD 3; Rohr, Ulrich-Peter MD, PhD 1
doi : 10.1200/JCO.23.01442
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
Conte, PierFranco MD, PhD 1,2,,; Bisagni, Giancarlo MD 3; Piacentini, Federico MD, PhD 4,; Sarti, Samanta MD, PhD 5; Minichillo, Santino MD 6; Anselmi, Elisa MD 7,; Aieta, Michele MD 8; Gebbia, Vittorio MD 9; Schirone, Alessio MD 10,; Musolino, Antonino MD, PhD 11,; Garrone, Ornella MD, PhD 12,; Beano, Alessandra MD 13; Rimanti, Anita MD 14; Giotta, Francesco MD 15; Turletti, Anna MD 16,; Miglietta, Federica MD 17,18,; Dieci, Maria Vittoria MD 17,18,; Vicini, Roberto PhD 19; Balduzzi, Sara MD 20; D'Amico, Robert PhD 4; Guarneri, Valentina MD, PhD 17,18,
doi : 10.1200/JCO.23.00790
Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality.
Lavery, Jessica A. MS 1,; Boutros, Paul C. PhD 2,3,4,5,; Scott, Jessica M. PhD 1,6; Tammela, Tuomas MD, PhD 7,; Moskowitz, Chaya S. PhD 1; Jones, Lee W. PhD 1,6,,
doi : 10.1200/JCO.23.00058
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naive Myelofibrosis.
Mascarenhas, John MD 1,,; Kremyanskaya, Marina MD, PhD 1,; Patriarca, Andrea MD 2,; Palandri, Francesca MD, PhD 3,; Devos, Timothy MD, PhD 4,; Passamonti, Francesco MD 5,; Rampal, Raajit K. MD, PhD 6,; Mead, Adam J. PhD 7,; Hobbs, Gabriella MD 8,; Scandura, Joseph M. MD, PhD 9,; Talpaz, Moshe MD 10,; Granacher, Nikki MD 11,; Somervaille, Tim C. P. PhD 12,; Hoffman, Ronald MD 1,; Wondergem, Marielle J. MD 13,; Salama, Mohamed E. MD 14,; Colak, Gozde PhD 15,; Cui, Jike PhD 15,; Kiladjian, Jean-Jacques MD, PhD 16,; Vannucchi, Alessandro M. MD 17,; Verstovsek, Srdan MD, PhD 18,; Curto-Garcia, Natalia MD 19; Harrison, Claire DM 19,; Gupta, Vikas MD 20,
doi : 10.1200/JCO.22.01972
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
Roy, Soumyajit MBBS, MSc 1,; Romero, Tahmineh MSc 2; Michalski, Jeff M. MD 3,; Feng, Felix Y. MD 4,; Efstathiou, Jason A. MD, DPhil 5,; Lawton, Colleen A.F. MD 6; Bolla, Michel MD 7; Maingon, Philippe MD 8,; de Reijke, Theo MD, PhD 9,; Joseph, David MBBS 10; Ong, Wee Loon MBBS, MPhil 11; Sydes, Matthew R. MSc 12,; Dearnaley, David P. MD 13,; Tree, Alison C. MD 14,; Carrier, Nathalie MSc 15; Nabid, Abdenour MD 16,; Souhami, Luis MD 17,; Incrocci, Luca MD, PhD 18; Heemsbergen, Wilma D. PhD 18; Pos, Floris J. MD, PhD 19,; Zapatero, Almudena MD, PhD 20,; Guerrero, Araceli MD 21; Alvarez, Ana MD 22,; San-Segundo, Carmen Gonzalez MD 22; Maldonado, Xavier MD 23,; Reiter, Robert E. MD 24,; Rettig, Matthew B. MD 25,; Nickols, Nicholas G. MD, PhD 26,; Steinberg, Michael L. MD 26,; Valle, Luca F. MD 26,; Ma, T. Martin MD, PhD 14,; Farrell, Matthew J. MD 26; Neilsen, Beth K. MD, PhD 26,; Juarez, Jesus E. MD 26; Deng, Jie MD, PhD 26; Vangala, Sitaram MS 2; Avril, Norbert MD 27,; Jia, Angela Y. MD, PhD 28,; Zaorsky, Nicholas G. MD, MS 28,; Sun, Yilun PhD 28,29; Spratt, Daniel MD 28,; Kishan, Amar U. MD 26,,; on behalf of the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators
doi : 10.1200/JCO.23.00617
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Slovin, Susan F. MD, PhD, FACP 1,,; Knudsen, Karen PhD 2,; Halabi, Susan PhD 3,; de Leeuw, Renee PhD 2,; Shafi, Ayesha PhD 2; Kang, Praneet MBS 1; Wolf, Steven MS 3; Luo, Bin PhD 3; Gopalan, Anuradha MD 1; Curley, Tracy BSN 1; Fleming, Mark MD 4,; Molina, Ana MD 5,; Fernandez, Celina BS 1; Kelly, Kevin DO 2,
doi : 10.1200/JCO.22.02639
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.
Raetz, Elizabeth A. MD 1,; Rebora, Paola PhD 2; Conter, Valentino MD 3,,; Schrappe, Martin MD 4,; Devidas, Meenakshi PhD 5,; Escherich, Gabriele MD 6; Imai, Chihaya MD 7,; De Moerloose, Barbara MD 8,; Schmiegelow, Kjeld MD 9,10,; Burns, Melissa A. MD 11,; Elitzur, Sarah MD 12,; Pieters, Rob MD 13,; Attarbaschi, Andishe MD 14,15,; Yeoh, Allen MD 16,; Pui, Ching-Hon MD 17,; Stary, Jan MD 18; Cario, Gunnar MD 4,; Bodmer, Nicole MD 19; Moorman, Anthony V. PhD 20,; Buldini, Barbara MD 21,; Vora, Ajay MD 22,; Valsecchi, Maria Grazia PhD 2,23
doi : 10.1200/JCO.23.00088
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
Kenter, Gemma G. MD, PhD 1,; Greggi, Stefano MD, PhD 2; Vergote, Ignace MD, PhD 3,; Katsaros, Dionyssios MD, PhD 4; Kobierski, Juliusz MD 5; van Doorn, Heleen MD, PhD 6; Landoni, Fabio MD, PhD 7; van der Velden, Jacobus MD, PhD 8; Reed, Nicholas MD, PhD 9,; Coens, Corneel PhD 10,; van Luijk, Iske MD 11; Colombo, Nicoletta MD, PhD 12,; Steen-Banasik, Elzbietta van der MD, PhD 13; Ottevanger, Nelleke MD, PhD 14,; Casado, Antonio MD, PhD 15,; on behalf of the EORTC-55994 Study Group; the EORTC-55994 Study Group; Schratter-Sehn, Annemarie; Vergote, Ignace; Vermorken, Jan Baptist; Altintas, Sevilay; Kridelka, Frederic; Goffin, Frederic; Joly-Lobbedez, Florence; Katsaros, Dionyssios; Greggi, Stefano; Colombo, Nicoletta; Landoni, Fabio; Zola, Paolo; Ferrero, Annamaria; Franchi, Massimo; Donadello, Nicoletta; Massuger, Leon; Ansink, Anca; Van Doorn, Helena; Van Der Velden, Jacobus; Verheijen, Rene; van Baal, W.M.; Kenter, Gemma; Van Dorst, Eleonora; Kenter, Gemma; Gaarenstroom, Katja; Kristensen, Gunnar; Kobierska, Anna; Kobierski, Julisz; de Oliveira, Carlos Freire; Frutuoso, Cristina; Casado Herraez, Antonio; Reed, Nicholas; Jyothirmayi, Rema; Nordin, Andrew; Rustin, Gordon
doi : 10.1200/JCO.22.02852
Myelofibrosis: In Search for BETter Targeted Therapies.
Palumbo, Giuseppe A. MD, PhD 1,,; Duminuco, Andrea MD 2,3,
doi : 10.1200/JCO.23.00833
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Del Rivero, Jaydira MD 1; Perez, Kimberly MD 2,; Kennedy, Erin B. MHSc 3; Mittra, Erik S. MD, PhD 4,; Vijayvergia, Namrata MD 5,; Arshad, Junaid MD 6,; Basu, Sandip MBBS 7; Chauhan, Aman MD 8,; Dasari, Arvind N. MD 9,; Bellizzi, Andrew M. MD 10; Gangi, Alexandra MD 11; Grady, Erin MD 12; Howe, James R. MD 10,; Ivanidze, Jana MD, PhD 13,; Lewis, Mark MD 14,; Mailman, Josh MBA 15,; Raj, Nitya MD 16,; Soares, Heloisa P. MD, PhD 17,; Soulen, Michael C. MD 18,; White, Sarah B. MD, MS 19,; Chan, Jennifer A. MD, MPH 2,; Kunz, Pamela L. MD 20,; Singh, Simron MD, MPH 21,; Halfdanarson, Thorvardur R. MD 22,; Strosberg, Jonathan R. MD 23,; Bergsland, Emily K. MD 24,
doi : 10.1200/JCO.23.01529
Playing by Eye: Using Music as a Parallel to Clinical Oncology.
Preti, Beatrice MD 1,
doi : 10.1200/JCO.23.01204
Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers.
Wang, Gang MD; Zhuo, Ning MD; Liu, Zhichun MD
doi : 10.1200/JCO.23.01039
Reply to G. Wang et al.
Park, Joo-Hyun MD, PhD; Hong, Jung Yong MD, PhD; Han, Kyungdo PhD
doi : 10.1200/JCO.23.01420
Analyzing the Impact of Exposure to Antibiotics on Immune Checkpoint Inhibitor Efficacy: Stop at a Methodological Checkpoint.
Poizeau, Florence MD, PhD; Dupuy, Alain MD, PhD
doi : 10.1200/JCO.23.00730
Reply to F. Poizeau et al.
Eng, Lawson MD, SM, FRCPC; Sutradhar, Rinku PhD; Krzyzanowska, Monika K. MD, MPH
doi : 10.1200/JCO.23.01191
